SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
830.00    14.00 (1.72%)
Bid:
824.00
Ask:
828.00
Spread: 4.00 (0.485%)
Market Cap: £382.60m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Contract Win

19 Nov 2010 07:00

RNS Number : 4394W
Porvair PLC
19 November 2010
 



For immediate release November 2010

 

Porvair plc ("Porvair")

Contract win

 

Porvair today announces that its subsidiary, Porvair Filtration Group Ltd, has signed a long term agreement with Parker Aerospace ("Parker") to provide filtration systems for Parker's on-board aircraft fuel tank inerting systems. The agreement secures sales to Porvair of up to $40M over 10 years.

 

Porvair and Parker have been collaborating for several years on the development of aircraft fuel tank inerting systems. These systems, supplied by Parker, are incorporated into passenger aircraft such as those manufactured by Boeing and Airbus.

 

Parker's lightweight system removes oxygen from a source of engine bleed air with an air separation module (ASM), before delivering nitrogen-enriched air into the aircraft fuel tanks. These ASM modules are particularly sensitive to contamination and are protected by Porvair's filtration system. The implementation of fuel tank inerting has been the subject of global regulation.

 

Scott Pearson, Parker Aerospace Fluid Systems Division Business Unit Manager of Fuel and Inerting, commented:

"Our alignment with Porvair as supplier of this critical filtration equipment is a testament to their technical capability and delivery performance to date. Their products ensure our inerting systems remain at the forefront of the technology."

 

Ben Stocks, Chief Executive of Porvair, said:

"This agreement comes towards the end of a good year for Porvair and is the result of many years of investment in new products. It is testament to the excellent design and engineering undertaken by the Porvair Filtration Group in Fareham. We are delighted to work with Parker on existing and future projects".

 

For further information, please contact:

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Finance Director

Buchanan Communications

0207 466 5000

Charles Ryland / Helen Chan

 

Notes to editors

 

Porvair plc

Porvair is a group of specialist filtration and environmental technology businesses. Its products are used in a range of niche filtration and environmental technology markets, and are derived from its expertise in the design and manufacture of filtration systems. Its Seal Analytical business is a market leader in the manufacture of laboratory based water analysis equipment.

 

Parker Aerospace

Parker Aerospace is an operating segment of Parker Hannifin Corporation. Parker Aerospace designs, manufactures, and services hydraulic, fuel, flight control, fluid conveyance, and engine components and systems for aerospace and other high-technology markets. Based in Irvine, California, its product lines include primary and secondary flight control actuation, power generation and control components, thrust-reverser actuation systems, electrohydraulic servovalves, electric motor-driven hydraulic pumps, fuel pumps, motor-operated valves and fuel equipment, lubrication oil reservoirs, lubrication and scavenge pumps, fuel measurement and management systems, cockpit instrumentation, flight inspection systems, lightning-safe products, pneumatic subsystems and components, fluid metering delivery and atomization devices, wheels, brakes, and fluid conveyance products such as hoses, tubes, disconnects, and fittings.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTFFDFDAFSSELF
Date   Source Headline
1st Mar 20239:30 amRNSTotal Voting Rights
2nd Feb 20235:42 pmRNSGrant of LTSP awards
30th Jan 20237:00 amRNSResults for the year ended 30 November 2022
17th Jan 20234:40 pmRNSSecond Price Monitoring Extn
17th Jan 20234:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSTrading Update, Notice of Results and Board Change
1st Dec 20224:00 pmRNSDirector/PDMR Shareholding
1st Dec 202210:00 amRNSTotal Voting Rights
29th Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20224:00 pmRNSBlock listing Interim Review
1st Nov 20227:00 amRNSTotal Voting Rights
27th Oct 20229:30 amRNSDirector declaration and resignation
12th Oct 20224:26 pmRNSDirector/PDMR Shareholding
5th Oct 20225:30 pmRNSHolding(s) in Company
5th Oct 20225:30 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSTrading Update-Ahead of Expectations
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
20th Sep 20224:41 pmRNSSecond Price Monitoring Extn
20th Sep 20224:36 pmRNSPrice Monitoring Extension
13th Sep 20227:00 amRNSNine Month Trading Update
9th Sep 20224:40 pmRNSSecond Price Monitoring Extn
9th Sep 20224:35 pmRNSPrice Monitoring Extension
8th Sep 20224:40 pmRNSSecond Price Monitoring Extn
8th Sep 20224:35 pmRNSPrice Monitoring Extension
7th Sep 20226:05 pmRNSDirector/PDMR Shareholding
6th Sep 20224:40 pmRNSHolding(s) in Company
2nd Sep 20223:06 pmRNSHolding(s) in Company
10th Aug 20224:40 pmRNSSecond Price Monitoring Extn
10th Aug 20224:36 pmRNSPrice Monitoring Extension
9th Aug 20224:36 pmRNSPrice Monitoring Extension
8th Jul 20227:00 amRNSDirector Declaration
5th Jul 20224:35 pmRNSPrice Monitoring Extension
4th Jul 20227:00 amRNSHalf Year Results 2022
30th Jun 20222:15 pmRNSDirector/PDMR Shareholding
29th Apr 20224:41 pmRNSSecond Price Monitoring Extn
29th Apr 20224:36 pmRNSPrice Monitoring Extension
28th Apr 20227:00 amRNSDirector/PDMR Shareholding
14th Apr 20221:42 pmRNSAGM resolutions
14th Apr 20227:00 amRNSAGM Trading Update
11th Mar 20224:41 pmRNSSecond Price Monitoring Extn
11th Mar 20224:36 pmRNSPrice Monitoring Extension
2nd Mar 20224:35 pmRNSPrice Monitoring Extension
28th Feb 20227:00 amRNSBlock listing Interim Review
28th Feb 20227:00 amRNSTotal Voting Rights
4th Feb 20223:00 pmRNSDirector/PDMR Shareholding
4th Feb 202212:20 pmRNSGrant of LTSP awards
3rd Feb 202211:27 amRNSDirector/PDMR Shareholding
31st Jan 20227:00 amRNSResults for the year ended 30 November 2021
14th Dec 202112:25 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.